ABIVAX SA (AAVXF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 19 48 sessions, July 21, 2025 to July 9, 2026
- Largest daily move
- +530.1% close of July 23, 2025
- 1-month change
- +37.3% closing prices, June 4, 2026 to July 9, 2026
Company Description
ABIVAX SA (OTC: AAVXF) is classified in the biotechnology industry within the Healthcare sector.
AAVXF gained 37.3% in the month to July 9, 2026. The last closing price was $139.00.
For FY2025, ABIVAX SA reported revenue of $5.4M with net income of -$394.4M and diluted earnings per share of -$5.67.
This page collects what Stock Titan holds for AAVXF, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
ABIVAX SA (AAVXF) closed at $139.00 on July 9, 2026. In the month to July 9, 2026, the price gained 37.3%.
AAVXF Metrics & Rankings
Price returns through July 9, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
ABIVAX SA has filed 10 recent SEC filings, including 4 Form 6-K, 2 Form SCHEDULE 13G/A, 2 Form 424B5, 1 Form F-6EF. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AAVXF SEC filings →
Financial Highlights
ABIVAX SA generated $5.4M in revenue in FY2025, operating income reached -$288.8M, and net income was -$394.4M. Diluted earnings per share stood at -$5.67. The company generated -$189.1M in operating cash flow. The current ratio was 8.75, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in ABIVAX SA (AAVXF) currently stands at 723.3 thousand shares, up 2.6% from the previous reporting period, representing 1.0% of the float. Since November 2025, short interest has increased by 63567.3%.
Days to Cover History
Days to cover for ABIVAX SA (AAVXF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 96052.9%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
AAVXF Company Profile & Sector Positioning
ABIVAX SA (AAVXF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing AAVXF often look at related companies in the same sector, including CSL Ltd (CMXHF), CSL Ltd (CSLLY), UCB SA NPV (UCBJF), UCB SA (UCBJY), and Genmab A/S DKK (GNMSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AAVXF's relative position within its industry.